Charles Ballantyne
Director of Finance/CFO presso HANSA BIOPHARMA AB
Patrimonio netto: - $ in data 30/04/2024
Profilo
Charles Evan Ballantyne currently works at PreveCeutical Medical, Inc., as Independent Director from 2023, Trovis Pharmaceuticals LLC, as Chief Financial Officer & Senior Vice President from 2006, and Hansa Biopharma AB, as Chief Financial Officer from 2024.
Mr. Ballantyne also formerly worked at Clinical Data, Inc., as Chief Financial Officer & Executive Vice President from 2010 to 2011, ACNielsen Corp., as Chief Operating Officer & Vice President, Agenus, Inc., as Chief Financial Officer from 2015 to 2016, Avedro, Inc., as Chief Financial Officer, Knowledge Impact, Inc., as Chief Financial Officer in 2002, Avalon Pharmaceuticals, Inc., as Chief Financial Officer & Senior Vice President from 2009 to 2012, Theriva Biologics, Inc., as Chief Financial Officer, Secretary & Treasurer from 2012 to 2015, Orchestra BioMed, Inc., as Chief Financial Officer, Oncxerna Therapeutics, Inc., as Chief Financial Officer from 2021 to 2023, and Gain Therapeutics, Inc., as Chief Financial Officer & Secretary from 2023 to 2024.
Mr. Ballantyne received his undergraduate degree from the University of Western Ontario and Masters Business Admin degree from the University of Windsor.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GAIN THERAPEUTICS, INC.
-.--% | 10/04/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Charles Ballantyne
| Società | Posizione | Inizio |
|---|---|---|
| PREVECEUTICAL MEDICAL INC. | Director/Board Member | 17/02/2023 |
| HANSA BIOPHARMA AB | Director of Finance/CFO | 01/03/2024 |
| Trovis Pharmaceuticals LLC | Director of Finance/CFO | 01/08/2006 |
Precedenti posizioni note di Charles Ballantyne
| Società | Posizione | Fine |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2024 |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Director of Finance/CFO | 01/01/2023 |
| AGENUS INC. | Director of Finance/CFO | 29/07/2016 |
| THERIVA BIOLOGICS, INC. | Director of Finance/CFO | 14/05/2015 |
Clinical Data, Inc.
 Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Director of Finance/CFO | 01/04/2011 |
Formazione di Charles Ballantyne
| University of Western Ontario | Undergraduate Degree |
| University of Windsor | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| AGENUS INC. | Health Technology |
| THERIVA BIOLOGICS, INC. | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| PREVECEUTICAL MEDICAL INC. | Health Technology |
| GAIN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Clinical Data, Inc.
Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Health Technology |
ACNielsen Corp.
 ACNielsen Corp. Miscellaneous Commercial ServicesCommercial Services ACNielsen Corp. provides market research, information and analysis services. The company was founded by Arthur C. Nielsen in 1923 and is headquartered in New York, NY. | Commercial Services |
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Knowledge Impact, Inc.
 Knowledge Impact, Inc. Packaged SoftwareTechnology Services Knowledge Impact, Inc. provides application software services. It offers e-learning and performance support solutions for enterprise applications such as CRM and ERP. The firm provides KnowledgeMate, an e-learning solution, as well as web-based and computer-based training. Knowledge Impact was founded in 1985 and is headquartered in Wayland, MA. | Technology Services |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
| Trovis Pharmaceuticals LLC | |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Health Technology |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Charles Ballantyne
